Clinical trial

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

NCT00179413 · Beth Israel Deaconess Medical Center, Other · Completed

Key facts

NCT number NCT00179413
Title Study of Long-term Peg Intron vs. Colchicine in Non-responders.
Official title Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial
Acronym COPILOT
Lead sponsor Beth Israel Deaconess Medical Center, Other
Collaborators Schering-Plough Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
Intervention type Drug
Interventions PEG -Intron, Colchicine
Enrollment 549
Start date Jan 15, 2000
Primary completion Dec 31, 2009
Completion Mar 3, 2010
First posted Sep 16, 2005
Last update posted Jul 11, 2017
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies